Keywords: ProStrakan, Kyowa Hakko Kiron, M&A

Kyowa Hakko to buy ProStrakan for around $474 million

Article | 21 February 2011

Print This

Troubled Scotland-based specialty drugmaker ProStrakan Group (LSE: PSK) has accepted a takeover bid from Japan’s Kyowa Hakko Kirin (4151: ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in